Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive
Research Triangle Park, NC 27709

 

December 13, 2023

 

Via EDGAR Correspondence

 

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F. Street, N.E.

Washington D. C. 20549

 

	Re:	Acceleration of Effective Date
		Fennec Pharmaceuticals Inc.
		Registration Statement on Form S-3
		File No. 333-275452

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m., Eastern Time, on December 15, 2023, or as soon thereafter as is practicable.

 

	Very truly yours,
	FENNEC PHARMACEUTICALS INC.
	By:	/s/ Rostislav Raykov
		Rostislav Raykov
		Chief Executive Officer